Alan Fuhrman, Director at Loxo Oncology, holds 2.40K shares in Tyra Bioscience (Ticker: TYRA), holds 30.40K shares in Esperion (Ticker: ESPR), holds 10.57K shares in Springworks Therapeutics (Ticker: SWTX).
Alan Fuhrman latest transaction was an Uninformative Buy of $11.62K.
What was Alan Fuhrman's most profitable transaction?
Alan Fuhrman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Alan Fuhrman's role in Loxo Oncology?
Alan Fuhrman's role in Loxo Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.